Thiazolidinediones Inhibit Aromatase Activity in Human Granulosa Cells by Interfering with Androgen Binding to Aromatase Takako Araki M.D. Dimiter Avtanski PhD Grishma Parikh M.D. Michael Goldman M.D. Zev Rosenwaks M.D. Leonid Poretsky M.D. Donna Seto-Young PhD. Department of Medicine Division of Endocrinology & Metabolism Beth Israel Medical Center Albert Einstein College of Medicine New York, NY
17
Embed
Thiazolidinediones Inhibit Aromatase Activity in Human Granulosa Cells by Interfering with Androgen Binding to Aromatase Takako Araki M.D. Dimiter Avtanski.
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
Thiazolidinediones Inhibit Aromatase Activity in Human Granulosa Cells by Interfering with Androgen Binding to
• TZDs are a group of medications used as insulin sensitizers in treatment of diabetes • TZDs, acting as PPAR- agonists, enhance insulin sensitivity of tissues and improve glucose tolerance in patients with insulin resistant states
• TZDs reduce hyperandrogenemia and restore ovulation in PCOS
Thiazolidinediones (TZDs)
AromataseAromataseCytochrome P-450 superfamilyCytochrome P-450 superfamilyProduct of the CYP19 geneProduct of the CYP19 geneHeme structure is responsible for binding Heme structure is responsible for binding androgenic steroidandrogenic steroidHighly expressed in placenta and granulosa Highly expressed in placenta and granulosa cellscellsKey enzyme that regulates estrogen Key enzyme that regulates estrogen synthesis in ovarysynthesis in ovaryPresent in subcutaneous fat (adipose Present in subcutaneous fat (adipose tissue), fetal liver, muscle, brain, bone, tissue), fetal liver, muscle, brain, bone, breast, and testisbreast, and testis
Aromatase enzyme expression was not changed by TZDs
TZD Effect on Substrate bindingto Aromatase
TZDs inhibit aromatase activity by interfering with substrate binding
1/V
1/S0
Competitive Inhibitor
Competitive Inhibitor
No Inhibitor
1/Km
Vmax
1/S
1/V
0
Non-competitive Inhibitor
Non-competitive Inhibitor
No Inhibitor
1/Km
Vmax
1/V
1/S0
Uncompetitive Inhibitor
Uncompetitive Inhibitor
No Inhibitor
1/Km
Vmax
Kinetic Study - Estradiol -
Km 6.4Km 11.3Km 7.3Km 10.6Km 9.8
SummarySummary~~in Human Granulosa Cells~in Human Granulosa Cells~
TZDs inhibit estrogen productionTZDs inhibit estrogen production
TZDs do not change aromatase mRNA or TZDs do not change aromatase mRNA or enzyme protein expressionenzyme protein expression
TZDs inhibit aromatase activity by interfering TZDs inhibit aromatase activity by interfering with androgen binding to aromatase, acting with androgen binding to aromatase, acting as uncompetitive inhibitorsas uncompetitive inhibitors
TZDs as Aromatase Inhibitors TZDs as Aromatase Inhibitors ~ ~ Future Directions and Future Directions and
Possible Clinical Implications Possible Clinical Implications ~~
Potential use in estrogen – dependent Potential use in estrogen – dependent diseases:diseases:Breast cancerBreast cancerEndometriosisEndometriosis
Our findings may explain in partOur findings may explain in part
the relationship between TZDs and the relationship between TZDs and osteoporosisosteoporosis
Thank youWe are thankful for the support fromWe are thankful for the support from
Gerald J. and Dorothy R. Friedman Gerald J. and Dorothy R. Friedman FoundationFoundation